Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

11 questions · 12 findings · 7 reviews

No studies found 9 · 75%GRADE not reported 2 · 16.7%Very low 0 · 0%Low 1 · 8.3%Moderate 0 · 0%High 0 · 0%

Casirivimab/imdevimab vs placebo

Quality of life at longest · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2

The review found no eligible studies for this question.

2 findings from 1 review

Intervention not reported

Quality of life up to longest · non‐hospitalised adults with mild COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Quality of life up to 28 days and longest · hospitalized people with mild to moderate symptomatic COVID‐19 (WHO scale 2 to 4) with severe comorbidities

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Quality of life up to 28 days and longest · unvaccinated, non‐hospitalized people with mild symptomatic COVID‐19 (WHO scale 2 to 3) at high risk for progression to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Summary of findings: Any alternative model of care vs usual care

Differences in quality of life ( · Nursing home residents (mean age 78.3 to 86.0 years; more than 66% women; 62.1% to 87.3% with dental prostheses)

Summary of findings: Any alternative model of care showed no clear difference in health‐related quality of life (mean difference) at longest compared with usual care (low certainty).

1 finding from 1 review